← Back to Search

Self- management program for Stroke

N/A

Waitlist Available

Led By Timothy Reistetter, PhD

Research Sponsored by The University of Texas Medical Branch, Galveston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in health distress from base line 2 (3 months) to follow-up (2 weeks from last day of intervention)

Awards & highlights

Study Summary

This trial is to study the feasibility of using a self-management program to improve outcomes for stroke patients, specifically those with chronic vision impairment.

Eligible Conditions

Stroke
Chronic Conditions

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected at follow-up (2 weeks from last day of intervention)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected at follow-up (2 weeks from last day of intervention)

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at follow-up (2 weeks from last day of intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility: Eligible Patients

Feasibility: Patient Refusals

Feasibility: Patient Withdrawals

+3 more

Secondary outcome measures

Change in self-reported self-efficacy, as measured by the Patient Reported Outcome Measure Information System (PROMIS) self-efficacy scale

Change in self-reported self-management, as measured by the Southampton Stroke Self-Management Questionnaire

Change in self-reported sleep, as measured by the PROMIS sleep disturbance and sleep-related impairments

+1 more

Other outcome measures

Change in self-reported health distress, as measured by the Health Distress Questionnaire

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard CareExperimental Treatment1 Intervention

The standard care group will receive baseline testing #1, standard care, baseline testing #2 and follow up testing approximately 8 weeks later.

Group II: ExperimentalExperimental Treatment1 Intervention

Experimental group will baseline testing #1, standard care, baseline testing #2 however then participate in a 6-week self-management intervention (either generic or vision specific self-management based) and then get 8 week follow up testing.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Science (NCATS)NIH

99 Previous Clinical Trials

36,281 Total Patients Enrolled

2 Trials studying Stroke

90 Patients Enrolled for Stroke

The University of Texas Medical Branch, GalvestonLead Sponsor

243 Previous Clinical Trials

56,643 Total Patients Enrolled

4 Trials studying Stroke

134 Patients Enrolled for Stroke

National Center for Advancing Translational Sciences (NCATS)NIH

321 Previous Clinical Trials

401,721 Total Patients Enrolled

6 Trials studying Stroke

698 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for the clinical trial still open?

"This particular medical trial is not currently recruiting, as indicated on clinicaltrials.gov; it was initially posted in September of 2019 and last updated in December 2021. Fortunately, 1043 other studies are still actively seeking patients at this time."

Answered by AI

What is the primary purpose of this clinical trial?

"This research endeavour seeks to evaluate the feasibility of eligible patients over a specific period. Secondary objectives encompass changes in self-reported self-management as captured by the Southampton Stroke Self-Management Questionnaire, vision quality of life through the National Eye Institute Vision Function Questionnaire -25 and PROMIS Self-Efficacy Scale capturing confidence levels regarding daily activities, symptoms, medications and treatments, emotions, and social interactions."

Answered by AI